Skip to content

Insider · CIK 0001929859

L. Jeremy Stigall

officer

Files at CLPT (ClearPoint Neuro, Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 10, 2025CLPT
ClearPoint Neuro, Inc.
FTax withholding
Common Stock
-3,561$13.29$47k70,747Jun 12, 2025
Mar 12, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Common Stock
+15,497--79,853Mar 14, 2025
Mar 12, 2025CLPT
ClearPoint Neuro, Inc.
FTax withholding
Common Stock
-5,545$13.18$73k74,308Mar 14, 2025
Mar 12, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Restricted Stock Unitsderivative
-15,497--61,990Mar 14, 2025
Mar 11, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Common Stock
+8,292--67,323Mar 13, 2025
Mar 11, 2025CLPT
ClearPoint Neuro, Inc.
FTax withholding
Common Stock
-2,967$12.70$38k64,356Mar 13, 2025
Mar 11, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Restricted Stock Unitsderivative
-8,292--8,291Mar 13, 2025
Mar 6, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Common Stock
+17,777--65,392Mar 10, 2025
Mar 6, 2025CLPT
ClearPoint Neuro, Inc.
FTax withholding
Common Stock
-6,361$13.19$84k59,031Mar 10, 2025
Mar 6, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Restricted Stock Unitsderivative
-17,777--17,778Mar 10, 2025
Mar 3, 2025CLPT
ClearPoint Neuro, Inc.
AGrant or award
Restricted Stock Unitsderivative
+44,280$0.00$044,280Mar 4, 2025
Feb 22, 2025CLPT
ClearPoint Neuro, Inc.
FTax withholding
Common Stock
-908$16.72$15k47,615Feb 25, 2025
Dec 31, 2024CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+251$4.53$1,13748,523Jan 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

L. Jeremy Stigall: insider trades and track record | InsiderTell